The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic characterisation of adenoid cystic carcinoma of the head and neck, lung, and breast.
 
Emily Heathcote
No Relationships to Disclose
 
Karan Patel
No Relationships to Disclose
 
Samuel Rack
No Relationships to Disclose
 
Clare Hodgson
Employment - The Christie Pathology Partnership; The Christie Pathology Partnership
 
Hitesh Mistry
Employment - SystemsForecastingUK
Leadership - OncoBayes Ltd.; SystemsForecastingUK
Stock and Other Ownership Interests - OncoBayes Ltd.; SystemsForecastingUK
Consulting or Advisory Role - SystemsForecastingUK
Patents, Royalties, Other Intellectual Property - OncoBayes Ltd.; SystemsForecastingUK
Travel, Accommodations, Expenses - SystemsForecastingUK
 
Guy Betts
No Relationships to Disclose
 
Paul Bishop
No Relationships to Disclose
 
Rachel Hall
No Relationships to Disclose
 
Anne C. Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
Consulting or Advisory Role - Gilead Sciences; MSD
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; MSD Oncology; Novartis
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Robert Metcalf
Honoraria - Bristol-Myers Squibb; MSD; Sanofi
Consulting or Advisory Role - Achilles Therapeutics; Aptus Clinical; Ayala Pharmaceuticals; Bayer; OxSonics Therapeutics; PCI Biotech